Shuji Nobori
Overview
Explore the profile of Shuji Nobori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohira M, Aoki G, Orihashi Y, Yoshimura K, Toshima T, Hatano E, et al.
BJS Open
. 2024 Aug;
8(4).
PMID: 39092977
Background: Validating the expanded criteria for living donor liver transplantation for hepatocellular carcinoma using national data is highly significant. The aim of this study was to evaluate the validity of...
2.
Tanino Y, Nishioka K, Yamamoto C, Watanabe Y, Daidoji T, Kawamoto M, et al.
Infect Drug Resist
. 2024 Feb;
17:531-541.
PMID: 38348230
Introduction: Various therapeutic agents are being developed for the treatment of coronavirus disease 2019 (COVID-19). Therefore, it is crucial to accumulate information regarding the features of drug-resistant viruses to these...
3.
Nakamura T, Shirouzu T, Sugimoto R, Harada S, Yoshikawa M, Nobori S, et al.
Transplant Proc
. 2022 Jan;
54(2):450-453.
PMID: 35039161
Background: There is no doubt that antibody-mediated rejection (AMR) due to donor-specific anti-HLA antibodies (DSA) brings a poor outcome for liver transplant recipients. However, the relationship between intragraft DSA (g-DSA),...
4.
Nakamura T, Nobori S, Harada S, Sugimoto R, Yoshikawa M, Ushigome H, et al.
Transplant Proc
. 2022 Jan;
54(2):438-442.
PMID: 35033371
Background: Living donor liver transplant between elderly donors and recipients has gained popularity, but the effects of their age remain unknown. Our aim is to evaluate the effects of matching...
5.
Nakamura T, Nobori S, Harada S, Sugimoto R, Yoshikawa M, Ushigome H, et al.
Transplant Proc
. 2022 Jan;
54(2):399-402.
PMID: 35033369
Background: It is true that multiple arterial reconstructions are sometimes required in living donor liver transplant (LDLT). However, the best procedure is still controversial regarding arterial reconstruction in liver grafts...
6.
Nakamura T, Shirouzu T, Harada S, Sugimoto R, Nobori S, Yoshikawa M, et al.
Transplantation
. 2021 Nov;
105(12):e407-e408.
PMID: 34818312
No abstract available.
7.
Nakamura T, Sugimoto R, Harada S, Nobori S, Ushigome H, Yoshikawa M
Exp Clin Transplant
. 2021 Nov;
19(12):1348-1351.
PMID: 34775940
Ogilvie syndrome (acute colonic pseudo-obstruction) is a rare, acquired, life-threatening disorder for which treatment plans vary from simple observation to surgical intervention. Ogilvie syndrome has been reported in patients after...
8.
Matsuyama T, Nakao T, Harada S, Nakamura T, Nobori S, Ushigome H
Am J Case Rep
. 2019 Aug;
20:1138-1140.
PMID: 31371695
BACKGROUND Splenic cysts are rare. Most are due to previous trauma, infection, or infarction. They are generally handled by laparoscopic surgical removal if they are larger than 5 cm. However,...
9.
Nakamura T, Shirouzu T, Kawai S, Imanishi Y, Matsuyama T, Harada S, et al.
Transplant Proc
. 2019 Jun;
51(5):1371-1377.
PMID: 31155175
Background: Graft immunocomplex capture fluorescence analysis is an attractive method to detect intragraft donor-specific anti-HLA antibodies. In ABO-incompatible transplantation, anti-A and B antibodies are also considered to be important donor...
10.
Nakamura T, Yoshimura N, Akioka K, Shirouzu T, Kawai S, Imanishi Y, et al.
Transplant Proc
. 2019 May;
51(5):1365-1370.
PMID: 31056246
Background: The management of acute or, in particular, chronic antibody-mediated rejection (AMR) resulting from donor-specific HLA antibodies (DSA) is a critical barrier to obtaining better long-term graft survival. To ascertain...